BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Ismail A, Amer MS, Tawheed A. Glucagon-like peptide-1 receptor agonists: Evolution, gastrointestinal adverse effects, and future directions. World J Gastrointest Pharmacol Ther 2025; 16(3): 107148 [PMID: 40937289 DOI: 10.4292/wjgpt.v16.i3.107148]
URL: https://www.wjgnet.com/2150-5349/full/v16/i3/107148.htm
Number Citing Articles
1
Krishna Bonga, Milan Padhan. Incretin Analogues for Weight Reduction in Non-Diabetic Obese: A Review of Liraglutide, Semaglutide, and Tirzepatide Beyond Glycemic ControlRambam Maimonides Medical Journal 2026; 17(1): e0006 doi: 10.5041/RMMJ.10565